-
1
-
-
0027208070
-
Angiotensin II receptors and angiotensin II receptor antagonists
-
Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 46:205-225.
-
(1993)
Pharmacol Rev.
, vol.46
, pp. 205-225
-
-
Timmermans, P.B.M.W.M.1
Wong, P.C.2
Chiu, A.T.3
Herblin, W.F.4
Benfield, P.5
Carini, D.J.6
Lee, R.J.7
Wexler, R.R.8
Saye, J.A.M.9
Smith, R.D.10
-
2
-
-
0028935595
-
Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
-
Goldberg AL, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol. 1995;75:793-795.
-
(1995)
Am J Cardiol.
, vol.75
, pp. 793-795
-
-
Goldberg, A.L.1
Dunlay, M.C.2
Sweet, C.S.3
-
3
-
-
0028942349
-
Blood pressure effects of the angiotensin II receptor blocker losartan
-
Weber MA, Byyny RL, Pratt JH, Faison EP, Snavely DB, Goldberg AI, Nelson EB. Blood pressure effects of the angiotensin II receptor blocker losartan. Arch Intern Med. 1995;155:405-411.
-
(1995)
Arch Intern Med.
, vol.155
, pp. 405-411
-
-
Weber, M.A.1
Byyny, R.L.2
Pratt, J.H.3
Faison, E.P.4
Snavely, D.B.5
Goldberg, A.I.6
Nelson, E.B.7
-
4
-
-
0025280867
-
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
-
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
-
(1990)
N Engl J Med.
, vol.322
, pp. 1561-1566
-
-
Levy, D.1
Garrison, R.J.2
Savage, D.D.3
Kannel, W.B.4
Castelli, W.P.5
-
5
-
-
0026092229
-
Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
-
Koren MJ, Devereux RB, Casale PN, Savage DD. Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
-
(1991)
Ann Intern Med.
, vol.114
, pp. 345-352
-
-
Koren, M.J.1
Devereux, R.B.2
Casale, P.N.3
Savage, D.D.4
-
6
-
-
0029064191
-
The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults
-
Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995;273: 1592-1597.
-
(1995)
JAMA
, vol.273
, pp. 1592-1597
-
-
Liao, Y.1
Cooper, R.S.2
McGee, D.L.3
Mensah, G.A.4
Ghali, J.K.5
-
7
-
-
0025859302
-
DuP753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet
-
Camargo MJF, von Lutterotti N, Pecker MS, James GD, Timmermans PBMWM, Laragh JH. DuP753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens. 1991;4(pt 2):341S-345S.
-
(1991)
Am J Hypertens.
, vol.4
, Issue.2 PART
-
-
Camargo, M.J.F.1
Von Lutterotti, N.2
Pecker, M.S.3
James, G.D.4
Timmermans, P.B.M.W.M.5
Laragh, J.H.6
-
8
-
-
0025831359
-
Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats
-
von Lutterotti N, Camargo MJF, Mueller FB, Timmermans PBMWM, Laragh JH. Angiotensin II receptor antagonist markedly reduces mortality in salt-loaded Dahl S rats. Am J Hypertens. 1991;4 (pt 2):346S-349S.
-
(1991)
Am J Hypertens.
, vol.4
, Issue.2 PART
-
-
Von Lutterotti, N.1
Camargo, M.J.F.2
Mueller, F.B.3
Timmermans, P.B.M.W.M.4
Laragh, J.H.5
-
9
-
-
0028261960
-
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat
-
Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
-
(1994)
Circulation
, vol.89
, pp. 2273-2282
-
-
Schieffer, B.1
Wirger, A.2
Meybrunn, M.3
Seitz, S.4
Holtz, J.5
Riede, U.N.6
Drexler, H.7
-
10
-
-
0029880710
-
Reduction of development of left ventricular hypertrophy in salt loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition
-
de Simone G, Devereux RB, Camargo MJF, Wallerson DC, Laragh JH. Reduction of development of left ventricular hypertrophy in salt loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition. Am J Hypertens. 1996;9:216-222.
-
(1996)
Am J Hypertens.
, vol.9
, pp. 216-222
-
-
De Simone, G.1
Devereux, R.B.2
Camargo, M.J.F.3
Wallerson, D.C.4
Laragh, J.H.5
-
11
-
-
0030902115
-
Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
Meurers, G.4
Cowley, A.J.5
Thomas, I.6
Deedwania, P.C.7
Ney, D.E.8
Snavely, D.B.9
Chang, P.I.10
-
12
-
-
0030872646
-
The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study. Rationale, design, and methods
-
Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. The Losartan Intervention For Endpoint Reduction (LIFE) in Hypertension Study. Rationale, design, and methods. Am J Hypertens. 1997;10:705-713.
-
(1997)
Am J Hypertens.
, vol.10
, pp. 705-713
-
-
Dahlöf, B.1
Devereux, R.2
De Faire, U.3
Fyhrquist, F.4
Hedner, T.5
Ibsen, H.6
Julius, S.7
Kjeldsen, S.8
Kristianson, K.9
Lederballe-Pedersen, O.10
Lindholm, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
13
-
-
0026437855
-
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product
-
Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992;20:1180-1186.
-
(1992)
J Am Coll Cardiol
, vol.20
, pp. 1180-1186
-
-
Molloy, T.J.1
Okin, P.M.2
Devereux, R.B.3
Kligfield, P.4
-
14
-
-
0028855273
-
Gender differences and the electrocardiogram in left ventricular hypertrophy
-
Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension. 1995;25:242-249.
-
(1995)
Hypertension
, vol.25
, pp. 242-249
-
-
Okin, P.M.1
Roman, M.J.2
Devereux, R.B.3
Kligfield, P.4
-
15
-
-
0028796192
-
Electrocardiographic identification of increased left ventricular mass by simple voltage duration products
-
Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage duration products. J Am Coll Cardiol. 1995;25:417-423.
-
(1995)
J Am Coll Cardiol.
, vol.25
, pp. 417-423
-
-
Okin, P.M.1
Roman, M.J.2
Devereux, R.B.3
Kligfield, P.4
-
16
-
-
0028824313
-
Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: Results of a correlated data base approach
-
Norman JE Jr, Levy D. Improved electrocardiographic detection of echocardiographic left ventricular hypertrophy: results of a correlated data base approach. J Am Coll Cardiol. 1995;26:1022-1029.
-
(1995)
J Am Coll Cardiol.
, vol.26
, pp. 1022-1029
-
-
Norman J.E., Jr.1
Levy, D.2
-
17
-
-
34547725544
-
The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and link leads
-
Sokolow M, Lyon TO. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and link leads. Am Heart J. 1949;37:161-186.
-
(1949)
Am Heart J.
, vol.37
, pp. 161-186
-
-
Sokolow, M.1
Lyon, T.O.2
-
18
-
-
0023102684
-
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer electrocardiogram interpretation
-
Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer electrocardiogram interpretation. Circulation. 1987-75: 565-572.
-
(1987)
Circulation
, vol.75
, pp. 565-572
-
-
Casale, P.N.1
Devereux, R.B.2
Alonso, D.R.3
Campo, E.4
Kligfield, P.5
-
19
-
-
0025959101
-
An updated coronary risk profile: A statement for health professionals
-
Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation. 1991; 83:356-362.
-
(1991)
Circulation
, vol.83
, pp. 356-362
-
-
Anderson, K.M.1
Wilson, P.W.F.2
Odell, P.M.3
Kannel, W.B.4
-
20
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
-
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
21
-
-
0025942936
-
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
-
Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
Schersten, B.4
Ekbom, T.5
Wester, P.O.6
-
22
-
-
0027416604
-
Management guidelines in essential hypertension: Report of the Second Working Party of the British Hypertension Society
-
Sever P, Beevers G, Bulpitt C, Lever C, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the Second Working Party of the British Hypertension Society. BMJ. 1993;306: 983-987.
-
(1993)
BMJ
, vol.306
, pp. 983-987
-
-
Sever, P.1
Beevers, G.2
Bulpitt, C.3
Lever, C.4
Ramsay, L.5
Reid, J.6
Swales, J.7
-
23
-
-
0030713021
-
The sixth report of Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
-
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
-
(1997)
Arch Intern Med.
, vol.157
, pp. 2413-2446
-
-
-
24
-
-
0027274762
-
Guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting
-
Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens. 1993;11:905-918.
-
(1993)
J Hypertens.
, vol.11
, pp. 905-918
-
-
-
25
-
-
0028006604
-
The Hypertension Optimal Treatment (HOT) Study: Patient characteristics, randomization, risk profiles, and early blood pressure results
-
Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment (HOT) Study: patient characteristics, randomization, risk profiles, and early blood pressure results. Blood Pressure. 1994;3: 322-327.
-
(1994)
Blood Pressure
, vol.3
, pp. 322-327
-
-
Hansson, L.1
Zanchetti, A.2
-
26
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S, for the HOT Study Group. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlöf, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
27
-
-
0029912251
-
How smoking affects blood pressure
-
Omvik P. How smoking affects blood pressure. Blood Pressure. 1996;5: 71-77.
-
(1996)
Blood Pressure
, vol.5
, pp. 71-77
-
-
Omvik, P.1
-
28
-
-
0030889729
-
Predictors of 7-year changes in exercise blood pressure: Effect of smoking, physical fitness and pulmonary function
-
Mundal R, Kjeldsen SE, Sandvik L, Erikssen G, Thaulow E, Erikssen J. Predictors of 7-year changes in exercise blood pressure: effect of smoking, physical fitness and pulmonary function. J Hypertens. 1997;15:245-249.
-
(1997)
J Hypertens.
, vol.15
, pp. 245-249
-
-
Mundal, R.1
Kjeldsen, S.E.2
Sandvik, L.3
Erikssen, G.4
Thaulow, E.5
Erikssen, J.6
|